Triglimifon LS 1 Tablet SR
Marketer
Foncer Pharma Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (7.5mg)
Overview Triglimifon LS 1 Tablet SR
Glycemicontrol-LS 1 Tablet SR, a combined-action medication, effectively manages blood glucose. Used alongside diet and exercise, it enhances blood sugar regulation in adults with type 2 diabetes. This medication promotes efficient insulin use, consequently reducing blood sugar. Always adhere to your physician's prescribed dosage and regimen for Glycemicontrol-LS 1 Tablet SR. Taking it with food minimizes stomach discomfort. If a dose is missed, take it promptly; however, if nearing the next dose, omit the missed one and resume your usual schedule. Never double the dose. An overdose can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk. Regular blood glucose monitoring is crucial. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or breastfeeding individuals must consult their physician before use. Kidney function tests will be performed before treatment begins. Limit alcohol consumption, as it may heighten the risk of side effects.
Primary Ingredients of Triglimifon LS 1 Tablet SR
No text provided to rephrase.
Uses of Triglimifon LS 1 Tablet SR
Managing Type 2 diabetes
Major Benefits of Triglimifon LS 1 Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Triglimifon LS 1 Tablet SR with a meal.
Common Side effects of Triglimifon LS 1 Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Triglimifon LS 1 Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Triglimifon LS 1 Tablet SR with a meal.
How Triglimifon LS 1 Tablet SR works:
Triglimifon LS 1 Tablet SR combines three distinct antidiabetic agents—glimepiride, metformin, and pioglitazone—to achieve superior blood glucose management when monotherapy or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Triglimifon LS 1 Tablet SR and alcohol is not advisable.
PregnancyCONSULT YOUR DOCTOR
The use of Triglimifon LS 1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Triglimifon LS 1 Tablet SR are likely incompatible. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Triglimifon LS 1 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.
LiverCAUTION
Patients with liver impairment should exercise caution when using Triglimifon LS 1 Tablet SR; dosage modification may be necessary. Consult a physician before use. Triglimifon LS 1 Tablet SR is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Triglimifon LS 1 Tablet SR :
Should you forget to take a Triglimifon LS 1 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Triglimifon LS 1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently